9 results on '"Li, Zhenhui"'
Search Results
2. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study
- Author
-
Li, Chunxia, Zhao, Ke, Zhang, Dafu, Pang, Xiaolin, Pu, Hongjiang, Lei, Ming, Fan, Bingbing, Lv, Jiali, You, Dingyun, Li, Zhenhui, and Zhang, Tao
- Published
- 2023
- Full Text
- View/download PDF
3. The Crohn’s-like lymphoid reaction density: a new artificial intelligence quantified prognostic immune index in colon cancer
- Author
-
Zhao, Minning, Yao, Su, Li, Zhenhui, Wu, Lin, Xu, Zeyan, Pan, Xipeng, Lin, Huan, Xu, Yao, Yang, Shangqing, Zhang, Shenyan, Li, Yong, Zhao, Ke, Liang, Changhong, and Liu, Zaiyi
- Published
- 2022
- Full Text
- View/download PDF
4. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
- Author
-
Li, Zhenhui, Zhu, Haibin, Pang, Xiaolin, Mao, Yun, Yi, Xiaoping, Li, Chunxia, Lei, Ming, Cheng, Xianshuo, Liang, Lei, Wu, Jiamei, Ding, Yingying, Yang, Jun, Sun, Yingshi, Zhang, Tao, You, Dingyun, and Liu, Zaiyi
- Subjects
- *
CARCINOEMBRYONIC antigen , *COHORT analysis , *CANCER relapse , *COLORECTAL cancer , *OVERALL survival , *RETROSPECTIVE studies - Abstract
Objective: Whether preoperative serum carbohydrate antigen 19-9 (CA19-9) is an independent prognostic factor and there are interactions of serum CA19-9 with carcinoembryonic antigen (CEA) on the risk of recurrence in colorectal cancer (CRC) patients are still not clarified.Methods: Consecutive patients with CRC who underwent curative resection for stage II-III colorectal adenocarcinoma at five hospitals were collected. Based on Cox models, associations of preoperative CA19-9 with recurrence-free survival (RFS) and overall survival (OS) were evaluated in patients with or without elevated CEA, and interactions between CEA and CA19-9 were also calculated. Restricted cubic spline (RCS) curves were used to evaluate the associations between preoperative CA19-9 and CRC outcomes on a continuous scale.Results: A total of 5048 patients (3029 [60.0%] men; median [interquartile range, IQR] age, 61.0 [51.0, 68.0] years; median [IQR] follow-up duration 46.8 [36.5-62.4] months) were included. The risk of recurrence increased with the elevated level of preoperative CA19-9, with the slope steeper in patients with normal CEA than those with elevated CEA. Worse RFS was observed for elevated preoperative CA19-9 (> 37 U/mL) (n = 738) versus normal preoperative CA19-9 (≤ 37 U/mL) (n = 4310) (3-year RFS rate: 59.4% versus 78.0%; unadjusted hazard ratio [HR]: 2.02; 95% confidence interval [CI]:1.79 to 2.28), and significant interaction was found between CA19-9 and CEA (P for interaction = 0.001). Increased risk and interaction with CEA were also observed for OS. In the Cox multivariable analysis, elevated CA19-9 was associated with shorter RFS and OS regardless of preoperative CEA level, even after adjustment for other prognostic factors (HR: 2.08, 95% CI:1.75 to 2.47; HR: 2.25, 95% CI:1.80 to 2.81). Subgroup analyses and sensitivity analyses yielded largely similar results. These associations were maintained in patients with stage II disease (n = 2724).Conclusions: Preoperative CA19-9 is an independent prognostic factor in CRC patients. Preoperative CA19-9 can be clinically used as a routine biomarker for CRC patients, especially with preoperative normal serum CEA. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
5. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
- Author
-
He, Lan, Huang, Yanqi, Chen, Xin, Huang, Xiaomei, Wang, Huihui, Zhang, Yuan, Liang, Changhong, Li, Zhenhui, Yan, Lixu, and Liu, Zaiyi
- Subjects
NON-small-cell lung carcinoma ,DISEASE risk factors ,FEATURE extraction ,DECISION making ,REGRESSION analysis - Abstract
Background: Despite the well-known role of immunoscore, as a prognostic tool, that appeared to be superior to tumor–node–metastasis (TNM) staging system, no prognostic scoring system based on immunohistochemistry (IHC) staining digital image analysis has been established in non-small cell lung cancer (NSCLC). Hence, we aimed to develop and validate an immune-based prognostic risk score (IMPRS) that could markedly improve individualized prediction of postsurgical survival in patients with resected NSCLC. Methods: In this retrospective study, complete resection of NSCLC (stage I–IIIA) was performed for two independent patient cohorts (discovery cohort, n=168; validation cohort, n=115). Initially, paraffin-embedded resected specimens were stained by immunohistochemistry (IHC) of three immune cell types (CD3+, CD4+, and CD8+ T cells), and a total of 5,580 IHC-immune features were extracted from IHC digital images for each patient by using fully automated pipeline. Then, an IHC-immune signature was constructed with selected features using the LASSO Cox analysis, and the association of signature with patients' overall survival (OS) was analyzed by Kaplan–Meier method. Finally, IMPRS was established by incorporating IHC-immune signature and independent clinicopathological variables in multivariable Cox regression analysis. Furthermore, an external validation cohort was included to validate this prognostic risk score. Results: Eight key IHC-immune features were selected for the construction of IHC-immune signature, which showed significant associations with OS in all cohorts [discovery: hazard ratio (HR)=11.518, 95%CI, 5.444–24.368; validation: HR=2.664, 95%CI, 1.029–6.896]. Multivariate analyses revealed IHC-immune signature as an independent prognostic factor, and age, T stage, and N stage were also identified and entered into IMPRS (all p <0.001). IMPRS had good discrimination ability for predicting OS (C-index, 0.869; 95%CI, 0.861–0.877), confirmed using external validation cohort (0.731, 0.717–0.745). Interestingly, IMPRS had better prognostic value than clinicopathological-based model and TNM staging system termed as C-index (clinicopathological-based model: 0.674; TNM staging: 0.646, all p <0.05). More importantly, decision curve analysis showed that IMPRS had adequate performance for predicting OS in resected NSCLC patients. Conclusions: Our findings indicate that the IMPRS that we constructed can provide more accurate prognosis for individual prediction of OS for patients with resected NSCLC, which can help in guiding personalized therapy and improving outcomes for patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer.
- Author
-
Xu, Zeyan, Li, Yong, Wang, Yingyi, Zhang, Shenyan, Huang, Yanqi, Yao, Su, Han, Chu, Pan, Xipeng, Shi, Zhenwei, Mao, Yun, Xu, Yao, Huang, Xiaomei, Lin, Huan, Chen, Xin, Liang, Changhong, Li, Zhenhui, Zhao, Ke, Zhang, Qingling, and Liu, Zaiyi
- Subjects
COLORECTAL cancer ,DEEP learning ,OVERALL survival ,SURVIVAL rate ,CONVOLUTIONAL neural networks ,SIGNAL convolution - Abstract
Background: Profound heterogeneity in prognosis has been observed in colorectal cancer (CRC) patients with intermediate levels of disease (stage II–III), advocating the identification of valuable biomarkers that could improve the prognostic stratification. This study aims to develop a deep learning-based pipeline for fully automatic quantification of immune infiltration within the stroma region on immunohistochemical (IHC) whole-slide images (WSIs) and further analyze its prognostic value in CRC. Methods: Patients from two independent cohorts were divided into three groups: the development group (N = 200), the internal (N = 134), and the external validation group (N = 90). We trained a convolutional neural network for tissue classification of CD3 and CD8 stained WSIs. A scoring system, named stroma-immune score, was established by quantifying the density of CD3
+ and CD8+ T-cells infiltration in the stroma region. Results: Patients with higher stroma-immune scores had much longer survival. In the development group, 5-year survival rates of the low and high scores were 55.7% and 80.8% (hazard ratio [HR] for high vs. low 0.39, 95% confidence interval [CI] 0.24–0.63, P < 0.001). These results were confirmed in the internal and external validation groups with 5-year survival rates of low and high scores were 57.1% and 78.8%, 63.9% and 88.9%, respectively (internal: HR for high vs. low 0.49, 95% CI 0.28–0.88, P = 0.017; external: HR for high vs. low 0.35, 95% CI 0.15–0.83, P = 0.018). The combination of stroma-immune score and tumor-node-metastasis (TNM) stage showed better discrimination ability for survival prediction than using the TNM stage alone. Conclusions: We proposed a stroma-immune score via a deep learning-based pipeline to quantify CD3+ and CD8+ T-cells densities within the stroma region on WSIs of CRC and further predict survival. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
7. Association Between Serum Carcinoembryonic Antigen Levels at Different Perioperative Time Points and Colorectal Cancer Outcomes.
- Author
-
Li, Zhenhui, Zhang, Dafu, Pang, Xiaolin, Yan, Shan, Lei, Ming, Cheng, Xianshuo, Song, Qian, Cai, Le, Wang, Zhuozhong, and You, Dingyun
- Subjects
COLORECTAL cancer ,CARCINOEMBRYONIC antigen ,CANCER prognosis ,OVERALL survival ,OLDER men ,SENSITIVITY analysis - Abstract
Background: Whether elevated postoperative serum carcinoembryonic antigen (CEA) levels are prognostic in patients with stage II colorectal cancer (CRC) remains controversial. Patients and Methods: Primary and sensitivity analysis populations were obtained from a retrospective, multicenter longitudinal cohort including consecutive patients without neoadjuvant treatment undergoing curative resection for stage I–III CRC. Serum CEA levels before (CEA
pre-m1 ) and within 1 (CEApost-m1 ), 2–3 (CEApost-m2–3 ), and 4–6 months (CEApost-m4–6 ) after surgery were obtained, and their associations with recurrence-free survival (RFS) and overall survival (OS) were assessed using Cox regression. Sensitivity and subgroup analyses were performed. Results: Primary and sensitivity analysis populations included 710 [415 men; age, 54.8 (11.6) years] and 1556 patients [941 men; age, 56.2 (11.8) years], respectively. Recurrence hazard ratios (HRs) in the elevated CEApre-m1 , CEApost-m1 , CEApost-m2–3 , and CEApost-m4–6 groups were 1.30 (95% CI: 0.91–1.85), 1.53 (95% CI: 0.89–2.62), 1.88 (95% CI: 1.08–3.28), and 1.15 (95% CI: 0.91–1.85), respectively. The HRs of the elevated CEApre-m1 , CEApost-m1 , CEApost-m2–3 , and CEApost-m4–6 groups for OS were 1.09 (95% CI: 0.60–1.97), 2.78 (95% CI: 1.34–5.79), 2.81 (95% CI: 1.25–6.30), and 3.30 (95% CI: 1.67–.536), respectively. Adjusted multivariate analyses showed that both in the primary and sensitivity analysis populations, elevated CEApost-m2–3 , rather than CEApre-m1 , CEApost-m1 , and CEApost-m4–6 , was an independent risk factor for recurrence, but not for OS. The RFS in the elevated and normal CEApost-m2–3 groups differed significantly among patients with stage II disease [n = 266; HR, 2.89; 95% CI, 1.02–8.24 (primary analysis); n = 612; HR, 2.69; 95% CI, 1.34–5.38 (sensitivity analysis)]. Conclusions: Elevated postoperative CEA levels are prognostic in patients with stage II CRC, with 2–3 months after surgery being the optimal timing for CEA measurement. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
8. A Nomogram Based on CT Deep Learning Signature: A Potential Tool for the Prediction of Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
- Author
-
Lin, Ting, Mai, Jinhai, Yan, Meng, Li, Zhenhui, Quan, Xianyue, and Chen, Xin
- Subjects
NON-small-cell lung carcinoma ,OVERALL survival ,DEEP learning ,NOMOGRAPHY (Mathematics) ,COMPUTED tomography ,SIGNAL convolution - Abstract
Purpose: To develop and further validate a deep learning signature-based nomogram from computed tomography (CT) images for prediction of the overall survival (OS) in resected non-small cell lung cancer (NSCLC) patients. Patients and Methods: A total of 1792 deep learning features were extracted from non-enhanced and venous-phase CT images for each NSCLC patient in training cohort (n=231). Then, a deep learning signature was built with the least absolute shrinkage and selection operator (LASSO) Cox regression model for OS estimation. At last, a nomogram was constructed with the signature and other independent clinical risk factors. The performance of nomogram was assessed by discrimination, calibration and clinical usefulness. In addition, in order to quantify the improvement in performance added by deep learning signature, the net reclassification improvement (NRI) was calculated. The results were validated in external validation cohort (n=77). Results: A deep learning signature with 9 selected features was significantly associated with OS in both training cohort (hazard ratio [HR]=5.455, 95% CI: 3.393– 8.769, P< 0.001) and external validation cohort (HR=3.029, 95% CI: 1.673– 5.485, P=0.004). The nomogram combining deep learning signature with clinical risk factors of TNM stage, lymphatic vessel invasion and differentiation grade showed favorable discriminative ability with C-index of 0.800 as well as a good calibration, which was validated in external validation cohort (C-index=0.723). Additional value of deep learning signature to the nomogram was statistically significant (NRI=0.093, P=0.027 for training cohort; NRI=0.106, P=0.040 for validation cohort). Decision curve analysis confirmed the clinical usefulness of this nomogram in predicting OS. Conclusion: The deep learning signature-based nomogram is a robust tool for prognostic prediction in resected NSCLC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis.
- Author
-
Zhao, Ke, Li, Zhenhui, Li, Yong, Yao, Su, Huang, Yanqi, Wang, Yingyi, Zhang, Fang, Wu, Lin, Chen, Xin, Liang, Changhong, and Liu, Zaiyi
- Subjects
- *
COLORECTAL cancer , *IMAGE analysis , *PROGNOSIS , *DIGITAL images , *INDIVIDUALIZED medicine - Abstract
Computerized image analysis for whole-slide images has been shown to improve efficiency, accuracy, and consistency in histopathology evaluations. We aimed to assess whether immunohistochemistry (IHC) image quantitative features can reflect the immune status and provide prognostic information for colorectal cancer patients. A fully automated pipeline was designed to extract histogram features from IHC digital images in a training set (N = 243). A Hist-Immune signature was generated with selected features using the LASSO Cox model. The results were validated using internal (N = 147) and external (N = 76) validation sets. The five-feature-based Hist-Immune signature was significantly associated with overall survival in training (HR 2.72, 95% CI 1.68–4.41, P <.001), internal (2.86, 1.28–6.39, 0.010), and external (2.30, 1.02–6.16, 0.044) validation sets. The full model constructed by integrating the Hist-Immune signature and clinicopathological factors had good discrimination ability (C-index 0.727, 95% CI 0.678–0.776), confirmed using internal (0.703, 0.621–0.784) and external (0.756, 0.653–0.859) validation sets. Our findings indicate that the Hist-Immune signature constructed based on the quantitative features could reflect the immune status of patients with colorectal cancer, which might advocate change in risk stratification and consequent precision medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.